|January 31, 2013|
|12:20 EDT||FTNT, CRUS, TPX, FIO, ISIS||Stocks with increasing option volume; ISIS TPX FTNT FIO CRUS |
News For ISIS;TPX;FTNT;FIO;CRUS From The Last 14 Days
|October 5, 2015|
|16:16 EDT||CRUS||On The Fly: Top stock stories for Monday|
The Dow began the day with a triple digit jump and continued to tack on gains from there, rising nearly 2% by the time the closing bell rang. The Nasdaq and S&P also posted significant gains in the market's broad based advance. The number of advancing stocks crushed the number of declining stocks while the up volume overwhelmed the down volume. The S&P 500 is now on a five day winning streak with earnings season set to unofficially begin on Thursday, when Alcoa (AA) releases its quarterly report after the close. ECONOMIC EVENTS: In the U.S., Markit's services PMI dropped to 55.1 in the final September print, compared to the preliminary reading of 55.6 and August's 56.1 figure. ISM's services index dropped 2.1 points to 56.9 in September, versus expectations for a more modest pullback to a reading of 57.5. COMPANY NEWS: General Electric (GE) was the best performer on the Dow, advancing $1.35, or 5.3%, to $26.82 after activist investor Nelson Peltz disclosed that his firm, Trian Fund Management, has accumulated a $2.5B stake, making it one of the company's top ten shareholders. Trian, which believes GE is "executing a bold transformation" from a broad conglomerate into an industrial company, predicted that GE stock may be worth $40-$45 per share by 2017... Shares of Twitter (TWTR) rose $1.85, or 7.03%, to $28.16 after the company appointed co-founder and interim Chief Executive Jack Dorsey as permanent CEO. Analysts welcomed the news, saying Dorsey was simply "too good to pass up" despite his concurrent role as head of payments company Square. Axiom analyst Victor Anthony upgraded the stock to Buy from Hold, though the rating change was made prior to this morning's CEO news, which had been previewed last week by Re/code, was confirmed by the company... The U.S., Japan and ten other countries came to terms on the Trans-Pacific Partnership, a trade agreement meant to open agricultural markets, tighten intellectual property rules and establish a group that will have the clout to challenge China's influence in the region. Reacting to the deal, Honeywell (HON) said trade agreements like the TPP have the potential to boost exports, support jobs, and increase access abroad, while Boeing (BA) pointed out that more than 70% of its commercial airplane revenue last year came from customers outside the U.S. MAJOR MOVERS: Among the notable gainers was Spark Therapeutics (ONCE), which surged $9.09, or 20.69%, to $53.02 after the Phase 3 trial of the company's lead gene therapy product met its primary endpoint. Also higher was SunEdison (SUNE), which gained 77c, or 9.31%, to $9.04 after announcing plans to optimize its business operations by refocusing on its core markets and simplifying its structure, among other initiatives. Among the noteworthy losers were a number of Apple (AAPL) chip suppliers, with Cirrus Logic (CRUS), Skyworks (SWKS) and Avago (AVGO) falling a respective 4.5%, 1.7%, and 2.6% after Citi analysts lowered fourth quarter iPhone sales estimates. Also lower was Valeant (VRX), which lost $18.86, or 10.34%, to $163.46 after its alleged "price hike" business strategy was highlighted in reports by the New York Times and Barron's. Additionally, AtriCure (ATRC) declined 8.8% to $20.47 after releasing preliminary third quarter results and agreeing to acquire cardiac device maker nContact. INDEXES: The Dow gained 304.06, or 1.85%, to 16,776.43, the Nasdaq advanced 73.49, or 1.56%, to 4,781.26, and the S&P 500 rose 35.69, or 1.83%, to 1,987.05.
|15:28 EDT||CRUS||Citi lowers iPhone unit sales estimates for Q4 |
Shares of Apple (AAPL) are underperforming a strong broader market rally after Citi lowered its fourth quarter iPhone unit sales estimates in a note to investors earlier. WHAT'S NEW: Not all of Apple's first weekend sales of iPhone 6S and 6S will be included in the company's Q4 earnings, Citi analyst Jim Suva wrote. Suva, who has a Buy rating and $145 target price on Apple shares, said that although first weekend sales of 13M units of iPhone 6S and 6S Plus exceeded sell side targets, Apple noted that not all of these units unit sales will be included in Apple's Q4 earnings given cut off of the reporting quarter. Only sales through Friday and Saturday of the weekend launch will be included in Q4. The remainder of the units sold on Sunday will be reported in December financial results, said Suva. As a result, Citi reduced its iPhone unit estimates to 47M from its prior view of 48M. This is below the Q4 consensus of 48M. The remaining units will be shifted to the December quarter. Citi expects many sell-side analysts to follow suit and lower their September quarter iPhone estimates in the weeks ahead before Apple reports on October 27. According to the Citi note, Apple share volatility will continue and the firm sees limited earnings and sales upside potential in the near-term causing some investors to exit the stock. The investment thesis for Apple is likely to shift from an iPhone "beat and raise" investment story to a gross margin upside story heading into a difficult comp year for iPhone 6S unit sales, Suva tells investors. He thinks any pullback will prove an attractive opportunity for long-term investors. WHAT'S NOTABLE: Late last week, an article from the DigiTimes said Apple may be adjusting its chip orders lower for Q4. Sources said that a substantial integrated circuit supplier is saying that Apple has "slightly lowered its demand for supplies for the new iPhones for December," the report said. The sources said that overall shipments of the iPhone 6s series are expected to reach 75M-80M units in Q3 and 65M-70M units in Q4.PRICE ACTION: In late afternoon trading, shares of Apple are underperforming broader market measures and are up 0.4% compared to a 1.75% gain for the S&P 500. OTHERS TO WATCH: Shares of Apple chip suppliers are also relatively weak, with Cirrus Logic (CRUS) down almost 4%, Skyworks Solutions (SWKS) sliding 2.5%, Qorvo (QRVO) trading near flat, Avago (AVGO) lower by 1.4%, and NXP Semiconductors (NXPI) down 0.25%.
|October 2, 2015|
|15:14 EDT||FTNT||As many as 4.6M Scottrade users' data exposed in breach, KrebsonSecurity says|
Subscribe for More Information
|10:02 EDT||TPX||High option volume stocks|
Subscribe for More Information
|October 1, 2015|
|12:44 EDT||CRUS||Apple chip suppliers fall after report iPhone maker may lower chip orders |
Shares of chip makers for Apple's (AAPL) iPhone are sliding after a DigiTimes article said the iPhone maker may curtail its chip orders for the fourth quarter. WHAT'S NEW: According to the DigiTimes report, Apple may be adjusting its chip orders lower for Q4. Sources said that a substantial integrated circuit supplier is saying that Apple has "slightly lowered lowered its demand for supplies for the new iPhones for December," the report said. The sources said that overall shipments of the iPhone 6s series are expected to reach 75M-80M units in the third quarter and 65M-70M units in Q4. WHAT'S NOTABLE: On September 28, Apple announced it has sold more than 13M new iPhone 6s and iPhone 6s Plus models just three days after launch, a new record for the company. According to an iFixit report from September 25, a teardown of the new iPhone 6S Plus revealed components supplied by Qualcomm (QCOM), Skyworks (SWKS), Qorvo (QRVO), Avago (AVGO), NXP Semiconductors (NXPI), Cirrus Logic (CRUS) and Texas Instruments (TXN), among others. Other chip makers that have been mentioned as possible Apple suppliers in the past include Analog Devices (ADI), Maxim Integrated Products. (MXIM) and ON Semiconductor (ON). PRICE ACTION: In midday trading shares of the aforementioned chip makers are all lower with Qorvo, Avago, NXP and Analog Devices down approximately 4% to 5%. Apple is down about 1.4%.
|September 30, 2015|
|10:33 EDT||FTNT||Battleground: Analysts agree Barracuda shares 'cheap,' diverge on ratings|
The shares of Barracuda Networks (CUDA) are falling after the company reported lower than expected revenue and provided weaker than expected guidance. Research firms Piper Jaffray and JPMorgan both said that the shares are cheap in the wake of their huge decline today, though Piper downgraded the shares and JPMorgan kept an Overweight rating on the stock. Barracuda provides IT security and storage solutions, primarily for small and medium businesses. WHAT'S NEW: Barracuda last night reported second quarter earnings per share of 10c, versus analysts' consensus estimate of 9c. The company's revenue, however, came in at $78.4M, below the consensus outlook of $78.7M. Moreover, the company lowered its fiscal 2016 EPS guidance to 34c-36c from 36c-41c. Analysts' consensus estimate was 39c. Barrcuda cut its full-year revenue guidance to $320M-$323M, from $325M-$330M. Analysts' consensus estimate was $325M. The company said that its Q2 results were negatively impacted by longer sales cycles in its Europe, Middle East, and Africa region and it warned that it "saw some evidence" of slowing growth in the storage market. It also stated that its gross billings came in below its expectations. ANALYST REACTION: Piper Jaffray analyst Andrew Nowinski responded to Barracuda's results by downgrading the stock to Neutral from Overweight. Although Barracuda blamed its lower than expected billings guidance on weakness in its storage business, its security billings increased only by high single digit percentage levels, the analyst stated. The shares are "cheap," but the valuation is not compelling enough to recommend the stock, contends Nowinski, who cut his price target for shares to $20 from $40. Barracuda was also downgraded at Macquarie and at Stephens this morning.Conversely, JPMorgan analyst Sterling Auty called Barracuda shares "too cheap to ignore." The company lowered its billings guidance partly due to worries about slowing storage market growth, as indicated by an industry report released last quarter, said Auty. However, the growth of Barracuda's storage business actually accelerated last quarter, reaching about 25%, the analyst stated. He believes that Barracuda's new guidance reflects the company's efforts to be "prudent." Auty cut his price target on the name to $30 from $42 but kept an Overweight rating on the shares. OTHERS TO WATCH: Other publicly traded companies in the IT security space include Check Point (CHKP), F5 Networks (FFIV), FireEye (FEYE), Fortinet (FTNT), Imperva (IMPV), Palo Alto (PANW), Proofpoint (PFPT), Qualys (QLYS) and Symantec (SYMC). PRICE ACTION: In early trading, Barracuda tumbled 33% to $15.90.
|September 27, 2015|
|14:04 EDT||FTNT||Cybersecurity firms look prime for takeover, Barron's says|
Cybersecurity companies like Palo Alto Networks (PANW), Fortinet (FTNT), and FireEye (FEYE) are becoming increasingly-attractive takeover targets for a Cisco (CSCO) or IBM (IBM), and any future dip in their stocks could represent a buying opportunity, Barron's contends in its 'Technology Trader' column. Reference Link
|September 25, 2015|
|16:17 EDT||CRUS||On The Fly: Top stock stories for Friday|
Stocks opened with sharp gains the day after Fed Chair Janet Yellen gave some clarity to the market by suggesting the Fed will most likely raise interest rates by the end of the year. During afternoon trading, the news flow slowed and the volume lightened on the buy side, leaving the sellers with the upper hand. The Nasdaq was the first index to move into negative territory, led by broad weakness in biotech stocks, while the Dow was helped to stay in the green by a big post-earnings move higher in Nike (NKE). The averages limped into the close, leaving the market with an interesting set-up to begin next week. Outside of stock news, it was certainly a headline packed day, as Speaker of the House John Boehner announced that he will resign at the end of October, Chinese President Xi Jinping continued his U.S. visit and Pope Francis addressed the United Nations while spending a second day in New York City. ECONOMIC EVENTS: In the U.S., the third estimate of second quarter GDP showed the economy grew 3.9% quarter-over-quarter, versus expectations for the GDP growth estimate to stay at 3.7%. Personal consumption in Q2 is now believed to have grown 3.6%, up from the prior estimate of 3.1%. The final University of Michigan consumer sentiment reading for September came in at 87.2, which was down from August's 91.9 but above the expected 86.2 reading... Federal Reserve Chair Janet Yellen said during a speech at UMass Amherst last night that the central bank remains inclined to hike rates this year. Yellen's remarks were incrementally hawkish, but welcomed by the market, since they helped clarify the message the Fed delivered a week ago. Of note, the Fed chair paused multiple times toward the end of her speech and received medical attention afterward, but returned to her regular schedule later in the evening, with the bank explaining that Yellen was dehydrated after a long day but was otherwise fine. COMPANY NEWS: Nike jumped $10.23, or 8.9%, to $125.02 after Thursday night's report of better than expected earnings and futures orders prompted numerous price target hikes at Street research firms. Additionally, Sterne Agee upgraded Nike to Buy from Neutral, saying it thinks the company is benefiting from its "global grass roots engagement with its customers," which enables it to meet its customers' needs and determine to what extent it can raise prices. The firm, which thinks that the company is continuing to gain share, has a $150 price target on the athletic gear giant... Biotech stocks, which were already having a bad week, ended the week on a down note, as the iShares NASDAQ Biotechnology Index (IBB) fell 4.9%, giving it a weekly decline of about 13%. Among the biggest large-cap losers in the space were Vertex (VRTX), which fell 7%, Regeneron (REGN), which dropped 6% and Celgene (CELG), which slid 4.8%. MAJOR MOVERS: Among the notable gainers was Jabil Circuit (JBL), which advanced $2.38, or 12.2%, to $21.88 after it reported higher than expected earnings and gave guidance for its November quarter that was significantly above expectations. Also higher was Cirrus Logic (CRUS), which gained $3.90, or 14.4%, to $31.03 after tear downs of Apple's (AAPL) iPhone 6S and 6S Plus led analysts to conclude that the chipmaker appears poised to obtain more revenue from the new devices than from the previous generation of the market-leading smartphone. Among the noteworthy losers was Finish Line (FINL), which fell $4.86, or 19.6%, to $19.91 after reporting second quarter revenue that missed expectations and saying it expects adjusted earnings this fiscal year to increase in a low single to mid single digits percentage from last year. Also lower following its earnings report was smartphone and software maker BlackBerry (BBRY), which slid 7.68% to $6.49 after the company posted a second quarter loss that was steeper than analysts expected. BlackBerry also confirmed press reports that it plans to launch a new phone that uses Google's (GOOG) Android operating system instead of its own proprietary BB10 OS. Shares of Aratana Therapeutics (PETX), which dropped $6.81, or 38.97%, to $10.68 after the company said that, based on "mixed clinical and scientific results," it does not believe that canine lymphoma products AT-004 and AT-005 in their current, first-generation forms will capture the desired lymphoma market opportunity. INDEXES: The Dow rose 113.35, or 0.7%, to 16,314.67, the Nasdaq fell 47.98, or 1.01%, to 4,686.50, and the S&P 500 added/slipped 0.90, or 0.05%, to 1,931.34.
|11:25 EDT||CRUS||Cirrus leads iPhone suppliers higher as analysts dissect 6S|
Cirrus Logic (CRUS), Skyworks (SWKS) and Qorvo (QRVO) are among the chipmakers that appear poised to obtain more revenue from Apple's (AAPL) iPhone 6S devices than from the previous generation of the market-leading smartphone. Research firms issued notes today based on their analysis of "teardowns" of the new phones after they went on sale for the first time, beginning in Australia. TEARDOWNS: Apple's common practice when rolling out its newest iPhone models is for Australia to be its first launch market. The unboxing of iPhones when they become available for sale for the first time anywhere in the world is a much anticipated event among the tech giant's fans, as well as by Apple-focused blogs and Wall Street analysts who follow the company. Websites like iFixit have become well known for their "teardowns" of the devices, where they purchase, take apart and analyze the way in which the device is made and how it differs from previous models. These teardowns are closely watched by analysts and can sometimes be catalysts for the stocks of iPhone component suppliers. CIRRUS: Barclays analyst Blayne Curtis says teardowns of Apple's iPhone 6S indicate Cirrus Logic secured both a smart codec and boosted amp win in the new phone. The company's content in each phone is likely towards the upper end of his $3.50-$4.00 estimate, Curtis tells investors, noting that he views this as better than expected. Curtis thinks the 6S content, coupled with the "several new growth drivers" Cirrus outlined at yesterday's technology day, could reverse the negative sentiment on the stock. He keeps an Overweight rating on the name with a $39 price target. OTHER WINNERS AND LOSERS: Skyworks and Qorvo saw their content rise 22% and 25% respectively, Curtis estimated. NXP Semiconductors (NXPI) is continuing to supply the NFC and Secure Element chips for the 6S devices, but is no longer providing the sensor hub, the analyst reported. The company will lose about 50c per iPhone as a result of this development, but it did know that it would no longer be providing the hub before it provided its guidance in July, according to Curtis. STMicroelectronics (STM) is no longer providing the secure MCU for the iPhone 6S, Curtis added. WHAT'S NOTABLE: Other companies that are supplying iPhone 6S components include Qualcomm (QCOM), Texas Instruments (TXN), and Avago (AVGO), iFixit reported. After conducting checks, Craig-Hallum analyst Anthony Stoss estimated that Skyworks will obtain about $6.50 of revenue per iPhone, up from about $5.50 previously, while Qorvo's revenue per device will rise to $6.25 from $5.75 and Avago will see its revenue per device increase to about $6.75 from about $6.50, Stoss believes. The firm kept Buy ratings on Skyworks, Avago, and Qorvo. PRICE ACTION: In morning trading, Cirrus shares jumped $4.36, or 16%, to $31.49, Skyworks added about 3% and Qorvo rose 4%. Meanwhile, NXP gained about 2% and STMicroelectronics advanced 2.5%.
|10:47 EDT||CRUS||Cirrus Logic volatility elevated on wide price movement|
Subscribe for More Information
|10:12 EDT||CRUS||High option volume stocks|
Subscribe for More Information
|10:07 EDT||CRUS||Cirrus Logic jumps 13% with iPhone 6S content viewed as better than expected|
Subscribe for More Information
|10:06 EDT||CRUS||Cirrus Logic content in iPhone 6S better than expected, says Barclays|
Barclays analyst Blayne Curtis says teardowns of Apple's (AAPL) iPhone 6S indicate Cirrus Logic (CRUS) secured both a smart codec and boosted amp win in the new phone. The company's content in each phone is likely towards the upper end of his $3.50-$4.00 estimate, Curtis tells investors in a research note. He views this as better than expected. Curtis thinks the 6S content, coupled with the "several new growth drivers" Cirrus outlined at yesterday's technology day, could reverse the negative sentiment on the stock. He keeps an Overweight rating on the name with a $39 price target. Cirrus is up $3.68 to $30.81 in early trading.
|09:48 EDT||CRUS||Apple iPhone 6S Plus teardown reveals chip suppliers, iFixit reports|
Subscribe for More Information
|September 24, 2015|
|07:36 EDT||FTNT||Fortinet checks positive, says Oppenheimer|
After conducting checks on Fortinet, Oppenheimer says the checks indicate that the company's results could come in at least at the higher end of its guidance. The firm says that the company continues to benefit from a number of positive catalysts, including more large deals and increased demand for high-end products. The firm keeps a $55 price target and Outperform rating on the stock.
|September 23, 2015|
|12:36 EDT||FTNT||Government cyber attack affects larger number of fingerprint data |
Subscribe for More Information
|September 22, 2015|
|10:01 EDT||ISIS||On The Fly: Analyst Initiation Summary|
Today's noteworthy initiations include: ACE Limited (ACE) initiated with a Buy at Sterne Agee CRT... AXIS Capital (AXS) initiated with a Neutral at Sterne Agee CRT... Abbott (ABT) initiated with a Neutral at UBS... Adamas Pharmaceuticals (ADMS) initiated with a Buy at Aegis... Advaxis (ADXS) initiated with an Overweight at Barclays... Allstate (ALL) initiated with a Buy at Sterne Agee CRT... Aon plc (AON) initiated with a Neutral at Sterne Agee CRT... Arch Capital (ACGL) initiated with a Neutral at Sterne Agee CRT... Ardelyx (ARDX) initiated with a Buy at BTIG... Aspen Insurance (AHL) initiated with a Neutral at Sterne Agee CRT... AtriCure (ATRC) initiated with a Sell at UBS... Baxalta (BXLT) initiated with a Buy at UBS... Baxter (BAX) initiated with a Neutral at UBS... Blue Buffalo Pet Products (BUFF) initiated with an Equal Weight at Stephens... Boston Scientific (BSX) initiated with a Buy at UBS... Capstone Turbine (CPST) initiated with a Buy at Rodman & Renshaw... CenturyLink (CTL) initiated with a Sector Perform at RBC Capital... Cerulean (CERU) initiated with an Overweight at Barclays... Chubb (CB) initiated with a Buy at Sterne Agee CRT... Cogent (CCOI) initiated with an Outperform at RBC Capital... Conatus (CNAT) initiated with a Buy at H.C. Wainwright... Edwards Lifesciences (EW) initiated with a Buy at UBS... Everest Re (RE) initiated with a Neutral at Sterne Agee CRT... Farmers National Banc (FMNB) initiated with an Outperform at Keefe Bruyette... Freshpet (FRPT) initiated with an Equal Weight at Stephens... Frontier Communications (FTR) initiated with a Sector Perform at RBC Capital... Globus Medical (GMED) initiated with a Buy at UBS... Halozyme (HALO) initiated with an Overweight at Barclays... Infoblox (BLOX) initiated with a Buy at Stifel... Isis Pharmaceuticals (ISIS) initiated with an Equal Weight at Barclays... Johnson & Johnson (JNJ) initiated with a Buy at UBSK2M Group (KTWO) initiated with a Buy at UBS... LDR Holding (LDRH) initiated with a Buy at UBS... Landmark Infrastructure (LMRK) initiated with a Buy at Wunderlich... Level 3 (LVLT) initiated with an Outperform at RBC Capital... Main Street (MAIN) initiated with an Outperform at RBC Capital... Marsh & McLennan (MMC) initiated with a Neutral at Sterne Agee CRT... Medtronic (MDT) initiated with a Buy at UBS... Middlefield Banc (MBCN) initiated with a Market Perform at Keefe Bruyette... Nokia (NOK) initiated with a Buy at CLSA... NuVasive (NUVA) initiated with a Buy at UBS... Piper Jaffray (PJC) initiated with a Buy at Sandler O'Neill... Planet Fitness (PLNT) initiated with an Outperform at Wedbush... Progressive (PGR) initiated with a Neutral at Sterne Agee CRT... QTS Realty Trust (QTS) initiated with an Outperform at RBC Capital... Reliance Steel (RS) initiated with a Sell at Rosenblatt... RenaissanceRe (RNR) initiated with a Neutral at Sterne Agee CRT... Spectranetics (SPNC) initiated with a Buy at Benchmark Co.... St. Jude Medical (STJ) initiated with a Buy at UBS... Stanley Black & Decker (SWK) initiated with a Neutral at Buckingham... Stryker (SYK) initiated with a Neutral at UBS... Travelers (TRV) initiated with a Neutral at Sterne Agee CRT... Vascular Biogenics (VBLT) initiated with a Buy at Chardan... W. R. Berkley (WRB) initiated with a Neutral at Sterne Agee CRT... WPX Energy (WPX) initiated with a Neutral at Citi... Wright Medical (WMGI) initiated with a Buy at UBS... XL Group (XL) initiated with a Buy at Sterne Agee CRT... Zendesk (ZEN) initiated with a Buy at Craig-Hallum... Zimmer Biomet (ZBH) initiated with a Neutral at UBS.
|06:35 EDT||ISIS||Isis Pharmaceuticals initiated with an Equal Weight at Barclays|
Subscribe for More Information